Patent · US Active

Vaccine against beta-herpesvirus infection and use thereof

US10842863B2 · kind B2 · utility

1Cited by

0References

20Claims

0Family size

Inventors

Christian Thirion · Nogent-sur-Oise, FR
Ulrich Koszinowski · Dießen am Ammersee, DE
Christian A. Mohr · Munich, DE
Zsolt Ruzsics · Dießen am Ammersee, DE

Key dates

Filing date	Nov 19, 2018
Grant date	Nov 24, 2020
Priority date	—
Expiry date	Nov 19, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2830/003
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention is related to a beta-herpesvirus, wherein the beta-herpesvirus is spread-deficient.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.